(Q34074926)

30 July 2017

1 reference

title

Evaluation of memantine for neuroprotection in dementia (English)

1 reference

30 July 2017

0 references

Jain KK

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

1397-1406

1 reference

Memantine in the treatment of senile dementia of the Alzheimer type.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Interaction of memantine and amantadine with agonist-unbound NMDA-receptor channels in acutely isolated rat hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Memantine prevents quinolinic acid-induced hippocampal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Protective effects of memantine against ischemia-reperfusion injury in spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Role of Na+/H+ exchangers, excitatory amino acid receptors and voltage-operated Ca2+ channels in human immunodeficiency virus type 1 gp120-mediated increases in intracellular Ca2+ in human neurons and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Memantine restores long term potentiation impaired by tonic N-methyl-D-aspartate (NMDA) receptor activation following reduction of Mg2+ in hippocampal slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Neuroprotection of acetylcholinergic basal forebrain neurons by memantine and neurokinin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Treatment of Impaired Cerebral Function in Psychogeriatric Patients with Memantine - Results of a Phase II Double-Blind Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Regionally different effects of scopolamine on NMDA antagonist-induced heat shock protein HSP70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1397

10.1517/13543784.9.6.1397

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference